Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL. — المؤلف: Felices, Martin — Blood advances 20200327

المؤلف
Felices, Martin
النشر
Blood advances 20200327
الوصف
897-907 p.
الموضوعات
Antigens, CD19؛ Antineoplastic Agents, Immunological؛ B-Lymphocytes؛ Cell Proliferation؛ Cells, Cultured؛ GPI-Linked Proteins؛ Humans؛ Immunotherapy